🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 6

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Fri, Dec 1, 2023 at 4:00 PM 75 replies 57,779 viewsPage 6 of 15
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Dec 2, 2023 at 12:30 AM#26
NurseAsh_DET said:
This community is amazing

This is exactly right. NurseAsh_DET articulated what I have been trying to explain to my doctor for months. The ClinicalTrials.gov GLP-1 aspect is the most important factor.

Last edited: Dec 2, 2023 at 5:30 AM
36 6SallyK_inj, CryptoCarl, MariaRD and 33 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Dec 2, 2023 at 12:47 AM#27

Saving this for reference. Top-tier content.

Last edited: Dec 2, 2023 at 3:47 AM
10 10laura_annarbor, JenMemphis, pat_auckland and 7 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Dec 2, 2023 at 1:04 AM#28

As a pharmacist, I want to add some clinical context to this discussion on ClinicalTrials.gov GLP-1 trial tracker .

Building on what NurseAsh_DET said — the evidence base here is robust. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
15 5robert_kc, dan_philly, MeganSA_TX and 12 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
Dec 2, 2023 at 1:21 AM#29

Reading this thread on ClinicalTrials.gov GLP-1 hits close to home. Dad of 2 checking in — I started at 297 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 72 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about ClinicalTrials.gov — take the leap. It was the best health decision I have ever made. ❤️

22 24Dr.PainCLE, mike_mealprep, NicoleRaleigh and 19 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Dec 2, 2023 at 1:38 AM#30

Congrats PharmD_Rodriguez!! Keep going — you're doing incredible. 🎉 👏

Last edited: Dec 2, 2023 at 4:38 AM
45 20mike_mod, SarahChen_PharmD, sarah.morrison and 42 others
Reply Quote Save Share Report
14567815

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register